• 1
    Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr. Clin. North Am. 1998; 21: 293307.
  • 2
    Yehuda R. Current status of cortisol findings in post-traumatic stress disorder. Psychiatr. Clin. North Am. 2002; 25: 341368.
  • 3
    Zanarini MC, Frankenburg FR, Dubo ED et al. Axis I comorbidity of borderline personality disorder. Am. J. Psychiatry 1998; 155: 17331739.
  • 4
    Wingenfeld K, Driessen M. The dexamethasone suppression test in borderline personality disorder: The impact of comorbid depressive and PTSD symptoms. In : CzerbskaMT (ed.). Psychoneuroendocrinology Research Trends. Nova Science Publishers, New York, 2007 (in press).
  • 5
    Lange W, Wulff H, Berea C et al. Dexamethasone suppression test in borderline personality disorder: Effects of posttraumatic stress disorder. Psychoneuroendocrinology 2005; 30: 919923.
  • 6
    Wittchen HU, Zaudig M, Fydrich T. Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen. SKID-I. Hogrefe, Göttingen, 1997.
  • 7
    Bernstein D, Fink L. CTQ Childhood Trauma Questionnaire. A Retrospective Self-Report. Psychological Corporation, San Antonio, TX, 1998.
  • 8
    Beck AT, Steer RA. Beck-Depressions-Inventar: BDI. Testhandbuch. Huber, Bern, 1994.
  • 9
    Wingenfeld K, Driessen M, Adam B, Hill A. Overnight urinary cortisol release in women with borderline personality disorder depends on comorbid PTSD and depressive psychopathology. Eur. Psychiatry 2007; 22: 309312.
  • 10
    Rinne T, De Kloet ER, Wouters L et al. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biol. Psychiatry 2002; 52: 11021112.